These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 21567388

  • 1. Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression.
    Ye YW, Zhou Y, Yuan L, Wang CM, Du CY, Zhou XY, Zheng BQ, Cao X, Sun MH, Fu H, Shi YQ.
    Cancer; 2011 Dec 01; 117(23):5304-13. PubMed ID: 21567388
    [Abstract] [Full Text] [Related]

  • 2. The correlations between the expression of FGFR4 protein and clinicopathological parameters as well as prognosis of gastric cancer patients.
    Ye YW, Zhang X, Zhou Y, Wu J, Zhao C, Yuan L, Wang G, Du C, Wang C, Shi Y.
    J Surg Oncol; 2012 Dec 01; 106(7):872-9. PubMed ID: 22585711
    [Abstract] [Full Text] [Related]

  • 3. Sox17 regulates proliferation and cell cycle during gastric cancer progression.
    Ye YW, Wu JH, Wang CM, Zhou Y, Du CY, Zheng BQ, Cao X, Zhou XY, Sun MH, Shi YQ.
    Cancer Lett; 2011 Aug 28; 307(2):124-31. PubMed ID: 21514720
    [Abstract] [Full Text] [Related]

  • 4. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H, Shen DP, Zhang ZZ, Liu JH, Shen YY, Ni XZ.
    World J Gastroenterol; 2015 Feb 14; 21(6):1838-44. PubMed ID: 25684949
    [Abstract] [Full Text] [Related]

  • 5. Silencing of FGFR4 could influence the biological features of gastric cancer cells and its therapeutic value in gastric cancer.
    Ye Y, Jiang D, Li J, Wang M, Han C, Zhang X, Zhao C, Wen J, Kan Q.
    Tumour Biol; 2016 Mar 14; 37(3):3185-95. PubMed ID: 26432329
    [Abstract] [Full Text] [Related]

  • 6. Combination of the FGFR4 inhibitor PD173074 and 5-fluorouracil reduces proliferation and promotes apoptosis in gastric cancer.
    Ye YW, Hu S, Shi YQ, Zhang XF, Zhou Y, Zhao CL, Wang GJ, Wen JG, Zong H.
    Oncol Rep; 2013 Dec 14; 30(6):2777-84. PubMed ID: 24126887
    [Abstract] [Full Text] [Related]

  • 7. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.
    Ye Y, Shi Y, Zhou Y, Du C, Wang C, Zhan H, Zheng B, Cao X, Sun MH, Fu H.
    Ann Surg Oncol; 2010 Dec 14; 17(12):3354-61. PubMed ID: 20844967
    [Abstract] [Full Text] [Related]

  • 8. Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.
    Ho HK, Pok S, Streit S, Ruhe JE, Hart S, Lim KS, Loo HL, Aung MO, Lim SG, Ullrich A.
    J Hepatol; 2009 Jan 14; 50(1):118-27. PubMed ID: 19008009
    [Abstract] [Full Text] [Related]

  • 9. Resistance to chemotherapy is associated with fibroblast growth factor receptor 4 up-regulation.
    Roidl A, Berger HJ, Kumar S, Bange J, Knyazev P, Ullrich A.
    Clin Cancer Res; 2009 Mar 15; 15(6):2058-66. PubMed ID: 19240166
    [Abstract] [Full Text] [Related]

  • 10. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
    Xu YF, Yang XQ, Lu XF, Guo S, Liu Y, Iqbal M, Ning SL, Yang H, Suo N, Chen YX.
    Biochem Biophys Res Commun; 2014 Mar 28; 446(1):54-60. PubMed ID: 24565842
    [Abstract] [Full Text] [Related]

  • 11. Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation.
    Sugiyama N, Varjosalo M, Meller P, Lohi J, Hyytiäinen M, Kilpinen S, Kallioniemi O, Ingvarsen S, Engelholm LH, Taipale J, Alitalo K, Keski-Oja J, Lehti K.
    Cancer Res; 2010 Oct 15; 70(20):7851-61. PubMed ID: 20876804
    [Abstract] [Full Text] [Related]

  • 12. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z, Cai SR, He YL, Zhan WH, Chen CQ, Cui J, Wu WH, Wu H, Song W, Zhang CH, Peng JJ, Huang XH.
    Ann Surg Oncol; 2009 Jan 15; 16(1):208-19. PubMed ID: 19009246
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Motoda N, Matsuda Y, Onda M, Ishiwata T, Uchida E, Naito Z.
    Int J Oncol; 2011 Jan 15; 38(1):133-43. PubMed ID: 21109934
    [Abstract] [Full Text] [Related]

  • 14. The over-expression of FGFR4 could influence the features of gastric cancer cells and inhibit the efficacy of PD173074 and 5-fluorouracil towards gastric cancer.
    Li J, Ye Y, Wang M, Lu L, Han C, Zhou Y, Zhang J, Yu Z, Zhang X, Zhao C, Wen J, Kan Q.
    Tumour Biol; 2016 May 15; 37(5):6881-91. PubMed ID: 26662569
    [Abstract] [Full Text] [Related]

  • 15. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
    Cai SR, Chen CQ, Wang Z, He YL, Cui J, Wu WH, Wu H, Zhan WH.
    Zhonghua Yi Xue Za Zhi; 2008 Aug 26; 88(33):2326-30. PubMed ID: 19087692
    [Abstract] [Full Text] [Related]

  • 16. Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer.
    Altan B, Yokobori T, Mochiki E, Ohno T, Ogata K, Ogawa A, Yanai M, Kobayashi T, Luvsandagva B, Asao T, Kuwano H.
    Carcinogenesis; 2013 Oct 26; 34(10):2314-21. PubMed ID: 23749771
    [Abstract] [Full Text] [Related]

  • 17. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 26; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer.
    Bai J, Zhou Y, Chen G, Zeng J, Ding J, Tan Y, Zhou J, Li G.
    Hum Pathol; 2011 Mar 26; 42(3):375-83. PubMed ID: 21190721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.